How has been the historical performance of Shelter Pharma?

Answer:The historical performance of Shelter Pharma shows a consistent growth trajectory in net sales and profitability over the years.

Breakdown:
Shelter Pharma's net sales have steadily increased from INR 30.06 crore in March 2022 to INR 50.66 crore in March 2025. This growth is accompanied by a rise in total operating income, which reached INR 50.66 crore in March 2025, up from INR 30.06 crore in March 2022. The company's total expenditure also grew, amounting to INR 40.59 crore in March 2025, compared to INR 27.38 crore in March 2022. Operating profit (PBDIT) has shown significant improvement, rising from INR 2.68 crore in March 2022 to INR 10.08 crore in March 2025, reflecting an operating profit margin of 19.88% in the latest fiscal year. Profit before tax increased from INR 2.51 crore in March 2022 to INR 9.68 crore in March 2025, with profit after tax also rising from INR 1.84 crore to INR 7.24 crore during the same period. The company's total assets grew from INR 12.84 crore in March 2022 to INR 48.30 crore in March 2025, while total liabilities increased from INR 12.84 crore to INR 48.30 crore, indicating a proportional growth in both assets and liabilities. Cash flow from operating activities improved significantly, reaching INR 5.00 crore in March 2025, compared to a negative cash flow of INR 1.00 crore in March 2024. Overall, Shelter Pharma demonstrates a robust upward trend in its financial performance across key metrics.